This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3oyp
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[ | + | ==HCV NS3/4A in complex with ligand 3== |
| + | <StructureSection load='3oyp' size='340' side='right' caption='[[3oyp]], [[Resolution|resolution]] 2.76Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[3oyp]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Hepatitis_c_virus_(isolate_japanese) Hepatitis c virus (isolate japanese)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3OYP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3OYP FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
| + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=0Y8:(4R)-4-[(7-BROMOISOQUINOLIN-1-YL)OXY]-L-PROLINE'>0Y8</scene>, <scene name='pdbligand=0Y9:(1R,2S)-1-AMINO-2-ETHENYLCYCLOPROPANECARBOXYLIC+ACID'>0Y9</scene>, <scene name='pdbligand=0YA:CYCLOPROPANESULFONAMIDE'>0YA</scene>, <scene name='pdbligand=DAL:D-ALANINE'>DAL</scene>, <scene name='pdbligand=PPI:PROPANOIC+ACID'>PPI</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3oyp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3oyp OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3oyp RCSB], [http://www.ebi.ac.uk/pdbsum/3oyp PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic apparatus. We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family. We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors. | ||
| - | + | Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine.,Hagel M, Niu D, St Martin T, Sheets MP, Qiao L, Bernard H, Karp RM, Zhu Z, Labenski MT, Chaturvedi P, Nacht M, Westlin WF, Petter RC, Singh J Nat Chem Biol. 2011 Jan;7(1):22-4. Epub 2010 Nov 28. PMID:21113170<ref>PMID:21113170</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | [[Category: Bernard, H]] | |
| - | == | + | [[Category: Chaturvedi, P C]] |
| - | < | + | [[Category: Hagel, M]] |
| - | [[Category: Bernard, H | + | [[Category: Karp, R M]] |
| - | [[Category: Chaturvedi, P C | + | [[Category: Labenski, M T]] |
| - | [[Category: Hagel, M | + | [[Category: Martin, T St]] |
| - | [[Category: Karp, R M | + | [[Category: Nacht, M]] |
| - | [[Category: Labenski, M T | + | [[Category: Niu, D]] |
| - | [[Category: Martin, T St | + | [[Category: Petter, R C]] |
| - | [[Category: Nacht, M | + | [[Category: Qiao, L]] |
| - | [[Category: Niu, D | + | [[Category: Sheets, M P]] |
| - | [[Category: Petter, R C | + | [[Category: Singh, J]] |
| - | [[Category: Qiao, L | + | [[Category: Westlin, W F]] |
| - | [[Category: Sheets, M P | + | [[Category: Zhu, Z]] |
| - | [[Category: Singh, J | + | |
| - | [[Category: Westlin, W F | + | |
| - | [[Category: Zhu, Z | + | |
[[Category: Hepatitis c virus]] | [[Category: Hepatitis c virus]] | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
Revision as of 12:14, 9 December 2014
HCV NS3/4A in complex with ligand 3
| |||||||||||
Categories: Bernard, H | Chaturvedi, P C | Hagel, M | Karp, R M | Labenski, M T | Martin, T St | Nacht, M | Niu, D | Petter, R C | Qiao, L | Sheets, M P | Singh, J | Westlin, W F | Zhu, Z | Hepatitis c virus | Hydrolase-hydrolase inhibitor complex | Ns3 | Ns4a | Protease inhibition | Serine protease
